Johns Hopkins Receives Grant from National Institute on Drug Abuse (NIDA) to Study Psilocybin for Tobacco Addiction

Psychedelic researcher Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, recently received a grant from the National Institute on Drug Abuse (NIDA) to study psilocybin for tobacco addiction.

“To my knowledge it’s the 1st grant from the U.S. government in over a half century to directly study therapeutics of a classic psychedelic,” wrote Johnson on Twitter.

The trials will take place at the University of Alabama at Birmingham (site leader Peter Hendricks) and New York University (site leader Michael Bogenschutz).